The Purpose of the study is to evaluate the efficacy of LN18178 in improving muscle strength, aerobic capacity and body composition in healthy young males.
Untrained healthy male subjects aged between 36 and 50 years with a Body Mass Index (BMI) between 22 and 27 kg/m2.
Willingness to do exercise training program during the course of the study.
Subject considered generally healthy as per health history and routine clinical investigations.
Ability to understand the risks and benefits of the protocol.
Subjects who are resistance trained or undergoing resistance training.
Subjects with blood pressure more than or equal to 140/90 mmHg, fasting plasma glucose more than 125 mg/dL and abnormal ECG.
Subjects underwent treatment for COVID-19 within last 3 months or tested positive during the study will be excluded.
Evidence or history of musculoskeletal, respiratory, haematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, neurologic diseases, malignancies.